SCHEMBL11118433

SCHEMBL11118433

CCC(=O)c1ccc(Cl)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
KDM4E B2RXH2 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
KDR P35968 1/20 0.47
HSP90AB1 P08238 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
KCNH2 Q12809 3/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
PLA2G1B P04054 1/20 0.44
HPGD P15428 1/20 0.44
XBP1 P17861 1/20 0.44
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11230620 0.85 TSHR (0.52) ALDH1A1MEN1KMT2AKDM4EFLT1
SCHEMBL25765618 0.85 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL10850438 0.85 ALDH1A1 (0.67) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL3919635 0.83 GSK3B (0.55) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL1144066 0.82 ALDH1A1 (0.69) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL29712843 0.82 ALDH1A1 (0.69) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL29115419 0.81 POLB (0.47) ALDH1A1KMT2ASMN1; SMN2HSP90AB1MAPK1
SCHEMBL6331423 0.81 HSP90AB1 (0.67) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL8688272 0.80 HTT (0.62) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL581464 0.80 HSD11B1 (0.54) ALDH1A1MEN1KMT2ASMN1; SMN2HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106660991-A Antiproliferative compounds and methods of use thereof 细胞基因公司 2017-05-10 CN disclosed
CN-100395234-C Novel CB1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2008-06-18 CN disclosed
CN-101012193-A Novel CB 1 receptour inverse agonists HOFFMANN LA ROCHE (CH) 2007-08-08 CN disclosed
CN-1735593-A Novel CB1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2006-02-15 CN disclosed
EP-0107198-A1 Use of 2-hydroxy-2-methyl-(p-chloropropionphenone) as a photoinitiator CIBA-GEIGY AG (CH) 1984-05-02 EP disclosed